Studies have demonstrated that the Se status is low in blood samples from COVID-19 patients and that the in situ SARS-CoV-2 infection significantly reduces the expression of a number of selenoproteins, including SEL P, S, K, GPx, and Trx [58,59]. The gene discussed is SELENOS; the disease is COVID-19.